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Copyright © 200? JCBN Summary Myristic acid (MyA), which is a saturated fatty acid (C14:0) and a side chain of
phorbol 12-myristate 13-acetate (PMA), was examined if MyA stimulates human poly-
morphonuclear leukocytes (PMNs) to release oxygen radicals comparable to PMA by applying
electron paramagnetic resonance (EPR)-spin-trapping method. When MyA was added to
isolated human PMNs, spin adducts of 5,5-dimethyl-1-pyrroline-N-oxide (DMPO)-OH and
DMPO-OOH were time-dependently observed. The amounts of these spin adducts were larger
than those of PMNs stimulated by PMA. These results clearly show that MyA is more potent
agent to prime human PMNs than PMA, in a point of view of not only O2￿− but also ·OH pro-
duction. This fact calls attention that too much intake of MyA that is known to be contained
vegetable oils can lead to crippling effect through uncontrolled production of reactive oxygen
species.
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Introduction
Polymorphonuclear leukocytes (PMNs) play an important
role in host defense against microbial infections. The micro-
bicidal mechanism consists of phagocytosis of pathogens,
production and subsequent release of reactive oxygen
species (ROS) and bactericidal proteins to phagosomes.
The process involves activation of NADPH oxidase (NOX),
which catalyzes the reduction of oxygen molecular to O2￿−
at the expense of NADPH in phagocytes [1–3]. NOXs are
a group of plasma membrane-associated multicomponent
enzymes consisting of at least two components bound to
plasma membrane (gp91phox and p22phox that together form
the flavocytochrome b558), and three cytosolic components
(p47phox, p67phox, and p40phox), and a small GTPase Rac [4].
In resting PMNs, NOXs are dormant and their components
separately exist in the membrane and in the cytosol. Once
PMNs are primed by appropriate stimuli, NOXs are acti-
vated to produce O2￿− by association of these cytosolic
components with the plasma or phagosome membrane com-
ponents [5–8]. Besides the bactericidal action as a beneficial
effect, the uncontrolled production of ROS by phagocytic
granulocytes may lead to crippling disorders such as shock
and inflammation [9].
Phorbol 12-myristate 13-acetate (PMA, Fig. 1), a potent
activator of protein kinase C (PKC), induces the phosphory-
lation of p47phox and subsequent O2￿− production by the
assembled NOX components [10]. More in detail, phospho-
rylation of proteins plays an essential role in the regulation
of NOX activity, and the activation of PKC with PMA
promotes the phosphorylation of serine and threonine resi-
dues of the p47phox and its translocation to the plasma
membrane [11–13]. The respiratory burst is accompaniedM. Tada et al.
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by tyrosine phosphorylation in cytosolic and membrane
proteins [14], and it is also well known that tyrosine phos-
phorylation of proteins occurs during priming of PMNs [15].
As shown in Fig. 1, a side chain group of PMA is myristic
acid (MyA), a 14-carbon, straight chain saturated fatty acid.
MyA is mainly contained in vegetable oils such as coconut
oil and palm oil, and likely affects lipid metabolism such as
hypercholesterolemia [16–18], i.e. MyA causes high LDL
cholesterol and apoB levels and low HDL to LDL ratios in
healthy men and women [16], a positive regression between
the plasma cholesterol level and the dietary level of MyA
was observed in hamsters [17], and incorporation of
trimyristin in the oil resulted in marked rise in serum
cholesterol of rats [18]. In term of oxidative metabolism of
PMNs, it was reported that MyA has an ability to stimulate
the generation of O2￿− from human neutrophils [19]. It was
reported that MyA induces the hydrolysis of phosphatidyl-
choline leading to generation of arachidonic acid (AA) [19].
AA when added with membrane protein separated from
bovine PMNs can activate NOX of bovine PMNs [20]. In
addition, it was reported that apocynin (a specific inhibitor
of NADPH oxidase) suppressed this stimuli (including
MyA) -dependent ROS generation of undifferentiated HL-
60 cells [21]. Thus, MyA may prime PMNs through two
routes, one is NOX activated by AA from phosphatidyl-
choline and the other is direct effect on NOX. Thus, to assess
the effect of MyA, when absorbed into the circulation, on
ROS generation, we need to estimate the potency of AA to
generate ROS in addition to the potency of MyA itself.
These findings tempted us to compare the stimulative effect
of MyA to release ROS with that of PMA, and to examine
the stimulative effect of AA as an indirect effect of MyA. In
this study, we examined stimuli-dependent ROS release
from human PMNs by applying electron paramagnetic
resonance (EPR)-spin-trapping method.
Materials and Methods
Reagents
Reagents were purchased from the following sources:
dextran, PMA, MyA and diethylenetriamine-N,N,N',N'',N''-
pentaacetic acid (DTPA) from Wako Pure Chemical Indus-
tries (Osaka, Japan), AA from ICN Biomedicals, Inc. (Costa
Mesa, CA), superoxide dismutase (SOD from bovine erythro-
cytes) and 4-hydroxyl-2,2,6,6-tetrametylpiperidin-1-oxyl
(TEMPOL) from Sigma-Aldrich (St. Lous, MO), Ficoll-
Paque Plus from Amersham Biosciences (Buckinghamshire,
UK) and 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) from
Labotec Inc. (Tokyo, Japan). All other reagents used were
of analytical grade.
Isolation of human PMNs
Heparinized venous blood was obtained from human
healthy volunteers. PMNs were prepared from the blood by
density gradient centrifugation using a Ficoll-Paque Plus
(d = 1.077) following dextran sedimentation as previously
described [22]. After the pellet of PMNs were subjected
to rapid hypotonic lysis of erythrocyte, the cells were
suspended in Hank’s balanced salt solution (HBSS) to be
1.0 × 106 cell/ml.
EPR-spin trapping determination of oxygen free radicals
generated from human PMNs
PMA and MyA were dissolved in dimethyl sulfoxide
(DMSO) to be 0.80 to 4.0 mM. AA was dissolved in DMSO
to be 3 and 30 mM. DTPA was dissolved in 0.1 M phosphate
buffer solution (PB, pH 7.4) to be 20 mM, SOD was to be
5000 U/ml in PB, and DMPO was to be 2.25 M in HBSS.
One hundred and twenty μl of cell suspension was mixed
with 16 μl of DMPO and 16 μl of DTPA solution. After
addition of 8 μl of PMA, MyA or AA, the resultant mixture
was transferred to a quartz flat EPR cell within 40 s. EPR
spectra of DMPO spin adducts were recorded at given times.
When necessary, 8 μl of SOD solution was added to the
mixture. The measurement conditions for EPR (JES-FA100,
JEOL, Tokyo, Japan) were as follows: scan rate, 10 mT/min;
scan field, 335.5 ± 5 mT; modulation width, 0.1 mT; modu-
lation frequency, 100 KHz; time constant, 0.03 s; micro-
wave power, 8 mW; and microwave frequency, 9.5 GHz.
Peak areas of EPR spectra of DMPO spin adducts, which are
compensated by the peak area of Mn2+, were compared with
those of the given concentrations of TEMPOL standard.
Statistical analysis
Each data is expressed as the mean ± standard error.
Statistical significances between the two mean values of
each time point were assessed by Student’s t test or Welch
t test following analysis of variance. Values of p<0.05 were
considered to be significant.
Fig. 1. Chemical structures of phorbol 12-myristate 13-acetate;
PMA and myristic acid; MyA.ROS Generation by Myristic Acid-Treated Neutrophils
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Results and Discussion
Fig. 2 shows the typical EPR spectra of DMPO spin
adducts of oxygen radicals generated from human PMNs
stimulated by PMA or MyA. As shown in Fig. 2A, multiple-
lines of EPR spectra of human PMNs primed by PMA
were detected. The hyperfine coupling constants (hfcc) of
aN = 1.48 and aH = 1.48 mT (closed circle) at the four-line
spectrum were typical DMPO spin adducts of ·OH (DMPO-
OH) [22,  23], and those of aN = 1.425, aH = 1.145 and
aH = 0.124 (open circle) were DMPO spin aducts of O2￿−
(DMPO-OOH) [21, 22]. Fig. 2B shows the representative
EPR spectra obtained from human PMNs primed by MyA.
As is the case with Fig. 2A, spin adducts of DMPO-OH
and DMPO-OOH were observed, suggesting that MyA can
stimulate human PMNs to release O2￿− and ·OH. To confirm
that the DMPO-OOH was derived from O2￿−, the PMNs were
treated with SOD, a potent O2￿− scavenger, prior to PMA and
MyA stimulation. Fig. 2C and D show characteristic EPR
spectra of DMPO-OH obtained from PMNs primed with
Fig. 2. EPR spectra of DMPO spin adducts of oxygen free radicals generated from human PMNs 1, 5.5 and 10 min after PMA- and
MyA-stimulation. A and B: EPR spectra of DMPO spin adducts from human PMNs with 81 μM PMA- and 81 μM MyA-stim-
ulation, respectively. Closed circles and open circles indicate DMPO spin adducts of ·OH (DMPO-OH) and O2￿− (DMPO-
OOH), respectively. C and D: EPR spectra of the DMPO spin adducts from PMA- and MyA-activetaed human PMNs pre-
treated with SOD, respectively. Closed circles indicate DMPO-OH.M. Tada et al.
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PMA and MyA following SOD treatment, respectively.
Since the twelve-line spectrum with the hfcc of aN =1 . 4 2 5 ,
aH = 1.145 and aH = 0.124 (open circle) was completely
disappeared in either of Fig. 2C and D, these spectra was
derived from spin adduct of DMPO and O2￿−.
Fig. 3A shows time course changes in DMPO-OOH
production after the addition of PMA, and of MyA to be a
concentration of 81 μM. Apparently MyA stimulated PMNs
to produce O2￿− more strongly than did PMA when the same
concentrations were added. Fig. 3B shows time course
changes in DMPO-OH production after the addition of
PMA, and MyA to be a concentration of 81 μM, indicating
that ·OH production was time-dependently increased by
either PMA or MyA. Similar to the case of O2￿−, MyA
stimulated PMNs to produce ·OH more strongly than did
PMA when the same concentrations were added. These
results clearly showed that MyA has an ability to prime
human PMNs to produce oxygen radicals such as O2￿− more
potently than PMA. It was reported that MyA induces
chemiluminescence of human promyelocytic leukemia cells
with a luminol analogue L-012 [24]. However, qualitative
analysis of ROS has not been conducted yet because
chemiluminescence is induced by various ROS [25]. On
the other hands, the EPR spin-trapping method could detect
O2￿− and ·OH simultaneously as DMPO-spin adducts as
shown in our study.
Fig. 4 shows the typical EPR spectra of DMPO-OOH and
DMPO-OH by human PMNs with 81 μM MyA, 150 μM
AA, and 1.5 mM AA. The EPR spectra were observed at
8 min after additions of MyA or AA. These findings show
that AA can also prime human PMNs to relerase O2￿− and
·OH, even though the potency is weaker than that of MyA.
Fig. 3. Time course changes in productions of DMPO spin
adducts of oxygen radicals by human PMNs treated with
81 μM PMA and MyA. A: DMPO-OOH productions
after PMA- and MyA stimulations. Each value repre-
sents the mean ± SEM of 8 determinations. Statistical
significances are shown by *; p<0.01 and **; p<0.005.
B: DMPO-OH productions after PMA- and MyA
stimulations. Each value represents the mean ± SEM of
8 determinations. Statistical significances are shown by
*; p<0.01 and **; p<0.005.
Fig. 4. EPR spectra of DMPO spin adducts of oxygen free
radicals generated from human PMNs 8 min after the
addition of MyA and AA. Closed circles and open
circles indicate DMPO spin adducts of ·OH (DMPO-
OH) and O2￿− (DMPO-OOH), respectively. In the top
figure, closed circles and open circles indicate DMPO
spin adducts of ·OH (DMPO-OH) and O2￿− (DMPO-
OOH), respectively. The signal other than DMPO-OH
and DMPO-OOH is DMPO-CR that is an adduct of
carbon-center radical derived from DMSO used as a
solvent of MyA. DMPO-CR, which is produced by a
chemical reaction between DMSO and ·OH, has six-line
spectrum with the hfcc of aN = 1.64, aH = 2.24 [27].ROS Generation by Myristic Acid-Treated Neutrophils
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As for the mechanism by which AA primes PMNs, it was
reported that AA activates NOX and proton channels of
dormant neutrophils [26].
The proposed mechanisms by which MyA primes human
PMNs are summarized in Fig. 5. Unlike C5a and N-formyl-
L-methionyl-L-leucyl-L-phenylalanine, both of which can
stimulate PMNs to produce O2￿− by inducing calcium (Ca)
influx, MyA-functions, like PMA-functions, bypass Ca influx
since it has been reported that MyA induces O2￿− production
from human neutrophils in the absence of Ca2+ and magne-
sium [19, 26]. Although the potency of AA to stimulate the
release of ROS is much weaker than that of MyA, the possi-
bility of involvement of AA to the effect of MyA when
absorbed into the circulation should be considered. Our
study shows that MyA is a more potent activator of PMNs
than PMA, and this fact calls attention that too much intake
of MyA can lead to crippling effect through uncontrolled
production of ROS.
Conclusions
We found that MyA is a stronger inducer of O2￿− and ·OH
generation by PMNs than PMA. MyA is mainly contained in
vegetable oils and likely affects lipid metabolism [16–18].
Too much intake of MyA-rich vegetable oil may work as an
inducer of PMNs’ activation, which may lead to undesirable
conditions of the body. In the future study, these points
should be elucidated.
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